https://www.um.edu.mt/library/oar/handle/123456789/27494 2026-04-11T11:31:33Z 2026-04-11T11:31:33Z Poruban, Rudolf Sagat, Michal Nosal, Matej Hraska, Viktor Omeje, Ikenna C. https://www.um.edu.mt/library/oar/handle/123456789/3991 2018-08-17T09:49:37Z 2004-01-01T00:00:00Z

Title: Surgical treatment of aortic coarctation Authors: Poruban, Rudolf; Sagat, Michal; Nosal, Matej; Hraska, Viktor; Omeje, Ikenna C. Abstract: Coarctation of the aorta accounts for about 8% of all congenital heart diseases. Since the first successful case of surgical treatment in 1944 by Crafoord and Nylin1 in Sweden, several surgical techniques have been employed in the treatment of this anomaly. This article reviews by illustration the various surgical options in coarctation of the aorta with emphasis on our preferred technique – the extended resection and end-to-end anastomosis. Why the extended resection technique? Our experience -and that of other institutions - has shown that this is a better option in childhood as it is associated with a lesser degree of recoarctation and subsequent need for reintervention.

2004-01-01T00:00:00Z Falzon, A. Grech, Victor E. DeGiovanni, Joseph V. https://www.um.edu.mt/library/oar/handle/123456789/3990 2017-07-18T09:33:16Z 2004-01-01T00:00:00Z

Title: Amplatzer device closure of an inferior venosus atrial septal defect after surgical closure of a secundum atrial septal defect Authors: Falzon, A.; Grech, Victor E.; DeGiovanni, Joseph V. Abstract: This article presents a patient who had transcatheter closure of a low atrial septal defect which was overlooked during surgical closure of a secundum atrial septal defect. The residual defect was detected during ablation for atrial flutter, and was closed successfully during the same procedure with an Amplatzer atrial septal occluder (ASO) device.

2004-01-01T00:00:00Z Fleck, Tatiana Wolner, E. Grabenwoger, M. Czerny, M. https://www.um.edu.mt/library/oar/handle/123456789/3989 2020-06-11T12:14:11Z 2004-01-01T00:00:00Z

Title: Interventional treatment methods in patients with Marfan Syndrome Authors: Fleck, Tatiana; Wolner, E.; Grabenwoger, M.; Czerny, M. Abstract: Marfan syndrome is an autosomal dominant heritable connective tissue disorder which involves primarily the skeletal, ocular and cardiovascular system. The incidence of MS is on average 1: 10000 with 25-30% of cases caused by sporadic mutations. The leading cause of premature death in these patients is progressive dilatation and subsequent dissection of the ascending thoracic aorta resulting in cardiac tamponade, and left ventricular failure due to aortic regurgitation. Life expectancy is primarily determined by the severity of cardiovascular involvement, and has improved substantially over the last 20 years due to the advances in surgical and medical management. The optimum management of Marfan patients includes a lifelong surveillance with particular emphasis placed on aortic behaviour. Preventive replacement of various portions of the aorta has been a major contribution for improved life expectancy in these patients. The different surgical and interventional treatment options currently available will be further outlined in this review.

2004-01-01T00:00:00Z